|
| Press Releases |
|
 |
|
| Thursday, May 2, 2024 |
|
|
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024 |
| The 16th Annual Global CSR & ESG Summit and Awards 2024 came to a triumphal close, marking another milestone in the realm of achievable corporate social responsibility (CSR) and environmental, social, and governance (ESG) initiatives. more info >> |
|
| Thursday, June 29, 2023 |
|
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
| BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
| Tuesday, December 6, 2022 |
|
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
| Monday, April 19, 2021 |
|
|
Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia |
| Cielo, the world's leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to help them hire the best talent in Asia. more info >> |
|
| Friday, April 26, 2019 |
|
|
Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER |
| Sanofi delivered strong Q1 2019 business EPS growth of 9.4% at CER. more info >> |
|
| Thursday, February 7, 2019 |
|
|
Sanofi delivers 2018 business EPS growth of 5.1% at CER |
| Sanofi announced the 2018 fourth-quarter and full-year results. more info >> |
|
| Wednesday, February 7, 2018 |
|
|
Sanofi Delivers 2017 Business EPS in line with Guidance |
| Sanofi Delivers 2017 Business EPS in line with Guidance more info >> |
|
| Monday, January 22, 2018 |
|
|
Sanofi to Acquire Bioverativ for $11.6 Billion |
| Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ for $105 per share in cash, representing an equity value of approximately $11.6 billion (on a fully diluted basis). The transaction was unanimously approved by both the Sanofi and Bioverativ Boards of Directors. more info >> |
|
| Friday, October 6, 2017 |
|
|
Sanofi: Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent(R) (alirocumab) |
| Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen's asserted patent claims for antibodies targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). This ruling means that Sanofi and Regeneron will continue marketing, selling and manufacturing Praluent(R) (alirocumab) injection in the U.S. more info >> |
|
| Thursday, February 13, 2014 |
|
|
A*STAR, NUS and NUH Join Forces to Understand Immune Erosion in Elderly |
| A*STAR's Singapore Immunology Network (SIgN) signed a three-year partnership with the National University of Singapore (NUS), National University Hospital (NUH) and Sanofi Pasteur to embark on a Phase IV clinical trial to understand age-related loss of immunity, known as immunosenescence, in elderly. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Kingnet Acquired Type 4 and Type 9 Licenses: Continuously Broadening Business Boundaries and Advancing Global Expansion Layout
Jul 14, 2025 23:47 HKT/SGT
|
|
|
愷英網絡獲得4號及9號牌照：持續拓寬業務邊界 全球化佈局更進一步
Jul 14, 2025 23:46 HKT/SGT
|
|
|
Graphene Aluminium Ion Battery Patent Granted and GMG and The University of Queensland Enter into New Collaboration Agreement
Jul 14, 2025 20:09 HKT/SGT
|
|
|
BlockBits Launches a Futures Trading Service, Offering Traders a Wide Range of Advanced Tools
Jul 14, 2025 20:00: JST
|
|
|
BlockBits Launches a Futures Trading Service, Offering Traders a Wide Range of Advanced Tools
Jul 14, 2025 20:00 HKT/SGT
|
|
|
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi's Desert Dragons facilities
Jul 14, 2025 18:00: JST
|
|
|
XDS Datacentres signs 15-year deal to host 10MW of AI workloads in Saudi's Desert Dragons facilities
Jul 14, 2025 17:00 HKT/SGT
|
|
|
恺英网络获得4号及9号牌照：持续拓宽业务边界 全球化布局更进一步
Jul 14, 2025 16:01 HKT/SGT
|
|
|
Buy International Homes at the Global Property Expo, Singapore
Jul 14, 2025 14:48 HKT/SGT
|
|
|
富士通、特化型AIエージェントでグローバルサプライチェーンを最適化するソリューションが、ビジネスを変革する先進事例として選定
Jul 14, 2025 11:00: JST
|
|
|
Fujitsu's AI-powered supply chain solution selected as transformative example of applied-AI technology by World Economic Forum
Jul 14, 2025 10:30 JST
|
|
|
"URECE" (Dotinurad) Launched in China as a treatment for Gout
Jul 14, 2025 10:20 JST
|
|
|
エーザイ、痛風治療剤「URECE」（一般名：ドチヌラド）を中国において新発売
Jul 14, 2025 09:00: JST
|
|
|
Mitsubishi Motors Added to FTSE4Good Index Series, FTSE Blossom Japan Index and FTSE Blossom Japan Sector Relative Index for Consecutive Years
Jul 11, 2025 16:28 JST
|
|
|
雲工場科技：錨定第二增長曲線 鑄就邊緣智能新時代
Jul 11, 2025 15:05 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
